In silico identification of compounds from Nigella sativa seed oil as potential inhibitors of SARS-CoV-2 targets

Nigella Sativa study #3 of 4 All Outcomes

3/12 In Silico

Duru et al., Bulletin of the National Research Centre, doi:10.1186/s42269-021-00517-x (Peer Reviewed)
In silico identification of compounds from Nigella sativa seed oil as potential inhibitors of SARS-CoV-2 targets

Source PDF Share Tweet

In Silico study of compounds from Nigella Sativa oil. Authors identify component phytochemicals with gas chromatography-mass spectrometry and analyze binding affinity with SARS-CoV-2 targets. Caryophyllene oxide, α-bergamotene, and β-bisabolene were identified as promising candidates for inhibition.

Duru et al., 3/12/2021, peer-reviewed, 3 authors.

All 4 studies All Outcomes

Please send us corrections, updates, or comments. Vaccines and treatments are both extremely valuable and complementary. All practical, effective, and safe means should be used. Elimination of COVID-19 is a race against viral evolution. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. Denying the efficacy of any method increases the risk of COVID-19 becoming endemic; and increases mortality, morbidity, and collateral damage. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. Treatment protocols for physicians are available from the FLCCC.

Submit